Migraine: A Problem for Employers and Managed Care Plans

American Journal of Managed Care

Volumn 3, Issue 10, 1997, Pages 1515-1523

  Warshaw, Leon J ^a,e   Burton, Wayne N ^b   Silberstein, Stephen D ^c   Lipton, Richard B ^d  

^a NEW YORK UNIVERSITY   (United States)

^b First National Bank of Chicago   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAILY LIFE ACTIVITY; DISEASE MANAGEMENT; EMPLOYMENT; HEALTH CARE QUALITY; HUMAN; MIGRAINE; REVIEW; UNITED STATES;

ACTIVITIES OF DAILY LIVING; DISEASE MANAGEMENT; EMPLOYMENT; HUMANS; MIGRAINE DISORDERS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 0031244563     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Stewart WF, Simon D, Schechter A, Lipton RB. Population variation in migraine prevalence: A meta-analysis. J Clin Epidemiol 1995;48:269-280.
2. Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches: A comparison of symptom-based and reported physician diagnosis. Arch Intern Med 1993;152:1273-1278.
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96.
4. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States: Relation to age, income, race and other sociodemographic factors. JAMA 1992;267:64-69.
5. Centers for Disease Control. Prevalence of chronic migraine headache, United States, 1980-1989. MMWR 1991;40:331-333.
6. Stang PE, Yanagihara T, Swanson JW, et al. Incidence of migraine headache: A population-based study in Olmstead County, Minnesota. Neurology 1992;42:1657-1662.
7. Sillanpaa M. Headache in children. In: Olesen J, ed. Headache Classification and Epidemiology. New York: Raven Press; 1994:273-281.
8. Mounstephen AH, Harrison RN. A study of migraine and its effects in a working population. Occup Med (Oxf) 1995; 45:311-317.
9. Stewart WF, Lipton RB, Simon D. Work-related disability: Results from the American Migraine Study. Cephalalgia 1996;16:231-238.
10. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labor costs of migraine headache in the United States. PharmacoEconomics 1992;2:67-76.
11. Celentano DD, Stewart WF, Lipton RB, Reed M. Medication use and disability among migraineurs. Headache 1992;32:223-228.
12. Lipton RB, Stewart WF, Von Korff M. The burden of migraine: A review of cost to society. PharmacoEconomics 1994;6:215-222.
13. Van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FFH. Societal perspective on the burden of migraine in the Netherlands. PharmacoEconomics 1995;7:170-179.
14. Clarke CE, MacMillan L, Sondhi S, Wells NE. Economic and social impact of migraine. Quart J Med 1996;89:77-84.
15. Leitman R, Cooner E, Schiffman S. The Pain and Absenteeism Report: A Study of Full-Time Employees and Employee Benefit Managers. New York: Louis Harris and Associates, Inc; 1996:10-12.
16. Olesen J, Lipton RB. Migraine classification and diagnosis: International Headache Society criteria. Neurology 1994;44(suppl 4):S6-S10.
17. Spierings EL, Sorbi M, Haimowitz BR, Tellegen B. Changes in daily hassles, mood and sleep in the 2 days before a migraine headache. Clin J Pain 1996;12:38-42.
18. Galiano L, Montiel I, Falip R, Asensio BR, Matias-Giui J. Stress as a precipitating factor in migraine. Rev Neurol 1995;23:830-832.
19. Silberstein SD. Advances in understanding the pathophysiology of headache. Neurology 1992;42(suppl 2):6-10.
20. Silberstein, SD. Advances in the pathophysiology of headache. Neurology 1993;42 (suppl 2):6-10.
21. Lance JW. Current concepts of migraine pathogenesis. Neurology 1993;43(suppl 3):S11-S15.
22. Campbell JK, Caselli RJ. Headache and other craniofacial pain. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in General Practice. 2nd ed., vol 2. Boston: Butterworth-Heinemann; 1996: 1683-1719.
23. Mathew NT, Kurman R, Perez F. Drug-induced refractory migraine - clinical features and management. Headache 1990;30:634-638.
24. Raskin NH. Acute and prophylactic treatment of migraine: Practical approaches and pharmacologic rationale. Neurology 1993;43(suppl 3):S39-S42.
25. Kirman C. Use of prescription drugs. Migraine Occupational Health Seminar. New York, New York, October 4 and 5, 1996.
26. Ziegler DK. The treatment of migraine. In: Dalessio DJ, ed. Wolff's Headache and Other Head Pain. 5th ed. New York: Oxford University Press; 1987:87-111.
27. Volans GN. Effects of metachlopramide on the absorption of effervescent aspirin in migraine. Brit J Clin Pharmacol 1975;2:57-63.
28. Ferrari MD, Haan J. Drug treatment of migraine attacks. In: Goadsby PJ, Silberstein SD, eds. Headache. Boston: Butterworth-Heinemann; 1997:117-130.
29. Dahlof C, Edwards C, Toth AL. Sumatriptan injection is superior to placebo in the acute treatment of migraine. Cephalalgia 1992;12:214-220.
30. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. Eur Neurol 1991;31:314-322.
31. Cady RK, Wendt JK, Kurchner JR, Sargent JD, Rothrock JF, Skaggs H Jr. Treatment of acute migraine with subcutaneous sumtriptan. JAMA 1991;265:2831-2835.
32. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991;325:316-321.
33. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother 1994;28:659-664.
34. Capobianco DJ, Cheshire WP, Campbell JK. An overview of the diagnosis and pharmacologic treatment of migraine. Mayo Clin Proc 1996;71:1055-1066.
35. Greiner DL, Addy SN. Sumatriptan use in a large group-model health maintenance organization. Am J Health Syst Pharm 1996;53:633-638.
36. Legg RF, Sclar DA, Nemec NL, Tarnai J, Mackowiak JI. Cost-effectiveness of sumatriptan in a managed care population. Am J Man Care 1997;3:117-122.
37. Lipton RB. Migraine: Prevalence and Impact. Migraine Occupational Health Seminar New York, New York, October 4 and 5, 1996.
38. General Accounting Office. Prescription Drugs and Medicine: Automated Review Systems Can Help Promote Safety, Save Money (GAO/AIMD-96-72, June 11, 1996). Washington, DC: US General Accounting Office.
39. Sacks O. Migraine: Understanding a Common Disorder. Berkeley, Calif: University of California Press; 1992:1-7.
40. Gooddy W. Foreword. In: Sacks O. Migraine: Understanding a Common Disorder. Revised and expanded. Berkeley, Calif: University of California Press; 1992:xxi.
41. Menken M. Commentary on "Intranasal lidocaine relieved acute migraine pain." ACP J Club 1997; 126:17. Comment on: Maizels M, Scott B, Cohen W, Chen W. Intranasal lidocaine for treatment of migraine. A randomized, double-blind, controlled trial. JAMA 1996;276:319-321.
42. Menken M. Commentary on "Intranasal lidocaine relieved acute migraine pain." ACP J Club 1997; 126:17. Comment on: Maizels M, Scott B, Cohen W, Chen W. Intranasal lidocaine for treatment of migraine. A randomized, double-blind, controlled trial. JAMA 1996;276:319-321.